METABOLISM OF 5(S)-HYDROXY-6,8,11,14-EICOSATETRAENOIC ACID AND OTHER 5(S)-HYDROXYEICOSANOIDS BY A SPECIFIC DEHYDROGENASE IN HUMAN POLYMORPHONUCLEAR LEUKOCYTES

被引:0
作者
POWELL, WS
GRAVELLE, F
GRAVEL, S
机构
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human polymorphonuclear leukocytes (PMNL) convert 6-trans isomers of leukotriene B4 (LTB4) to dihydro metabolites (Powell, W. S., and Gravelle, F. (1988) J. Biol. Chem. 263, 2170-2177). In the present study we investigated the mechanism for the initial step in the formation of these products. We found that the 1,500 x g supernatant fraction from human PMNL converts 12-epi-6-trans-LTB4 to its 5-oxo metabolite which was identified by mass spectrometry and UV spectrophotometry. The latter compound was subsequently converted to the corresponding dihydro-oxo product, which was further metabolized to 6,11-dihydro-12-epi-6-trans-LTB4, which was the major product after longer incubation times. The 5-hydroxyeicosanoid dehydrogenase activity is localized in the microsomal fraction and requires NADP+ as a cofactor. These experiments therefore suggest that the initial step in the formation of dihydro metabolites of 6-trans isomers of LTB4 is oxidation of the 5-hydroxyl group by a microsomal dehydrogenase. Studies with a variety of substrates revealed that the microsomal dehydrogenase in human PMNL oxidizes the hydroxyl groups of a number of other eicosanoids which contain a 5(S)-hydroxyl group followed by a 6-trans double bond. There is little or no oxidation of hydroxyl groups in the 8-, 9-, 11-, 12-, or 15-positions of eicosanoids, or of the 5-hydroxyl group of LTB4, which has a 6-cis rather than a 6-trans double bond. The preferred substrate for this enzyme is 5(S)-hydroxy-6,8,11,14-eicosatetraenoic acid (5(S)-HETE) (K(m), 0.2-mu-M), which is converted to 5-oxo-6,8,11,14-eicosatetraenoic acid. Unlike 5(S)-HETE, 5(R)-HETE is a poor substrate for the 5(S)-hydroxyeicosanoid dehydrogenase, indicating that in addition to exhibiting a high degree of positional specificity, this enzyme is also highly stereospecific. In addition to 5(S)-HETE and 6-trans isomers of LTB4, 5,15-diHETE is also a good substrate for this enzyme, being converted to 5-oxo-15-hydroxy-6,8,11,13-eicosatetraenoic acid (5-oxo-15-hydroxy-ETE). The oxidation of 5(S)-HETE to 5-oxo-ETE is reversible since human PMNL microsomes stereospecifically reduce 5-oxo-ETE to the 5(S)-hydroxy compound in the presence of NADPH. 5-Oxo-ETE is formed rapidly from 5(S)-HETE by intact human PMNL, but because of the reversibility of the reaction, its concentration only reaches about 25% that of 5(S)-HETE.
引用
收藏
页码:19233 / 19241
页数:9
相关论文
共 50 条
[41]   Metabolism and pharmacokinetics of a potent N-acylindole antagonist of the OXE receptor for the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) in rats and monkeys [J].
Reddy, Chintam Nagendra ;
Alhamza, Hussam ;
Chourey, Shishir ;
Ye, Qiuji ;
Gore, Vivek ;
Cossette, Chantal ;
Gravel, Sylvie ;
Slobodchikova, Irina ;
Vuckovic, Dajana ;
Rokach, Joshua ;
Powell, William S. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 115 :88-99
[42]   A GENERAL STRATEGY FOR THE SYNTHESIS OF MONOHYDROXYEICOSATETRAENOIC ACIDS - TOTAL SYNTHESIS OF 5(S)-HYDROXY-6(E),8,11,14(Z)-EICOSATETRAENOIC ACID (5-HETE) AND 12(S)-HYDROXY-5,8,14(Z),10(E)-EICOSATETRAENOIC ACID (12-HETE) [J].
NICOLAOU, KC ;
LADDUWAHETTY, T ;
TAFFER, IM ;
ZIPKIN, RE .
SYNTHESIS-STUTTGART, 1986, (04) :344-347
[43]   In vivo α-hydroxylation of a 2-alkylindole antagonist of the OXE receptor for the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid in monkeys [J].
Chourey, Shishir ;
Ye, Qiuji ;
Reddy, Chintam Nagendra ;
Cossette, Chantal ;
Gravel, Sylvie ;
Zeller, Matthias ;
Slobodchikova, Irina ;
Vuckovic, Dajana ;
Rokach, Joshua ;
Powell, William S. .
BIOCHEMICAL PHARMACOLOGY, 2017, 138 :107-118
[44]   5-oxo-6,8,11,14-eicosatetraenoic acid induces important eosinophil transmigration through basement membrane components -: Comparison of normal and asthmatic eosinophils [J].
Guilbert, M ;
Ferland, C ;
Bossé, M ;
Flamand, N ;
Lavigne, S ;
Laviolette, M .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1999, 21 (01) :97-104
[45]   5-oxo-6,8,11,14-eicosatetraenoic acid stimulates the release of the eosinophil survival factor granulocyte/macrophage colony-stimulating factor from monocytes [J].
Stamatiou, PB ;
Chan, CC ;
Monneret, G ;
Ethier, D ;
Rokach, J ;
Powell, WS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (27) :28159-28164
[46]   Structure-activity relationship study of β-oxidation resistant indole-based 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) receptor antagonists [J].
Ye, Qiuji ;
Chourey, Shishir ;
Wang, Rui ;
Chintam, Nagendra Reddy ;
Gravel, Sylvie ;
Powell, William S. ;
Rokach, Joshua .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (20) :4770-4776
[47]   5-oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of L-selectin shedding, surface expression of CD11b, actin polymerization, and calcium mobilization in human eosinophils [J].
Powell, WS ;
Gravel, S ;
Halwani, F .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1999, 20 (01) :163-170
[48]   Novel Highly Potent and Metabolically Resistant Oxoeicosanoid (OXE) Receptor Antagonists That Block the Actions of the Granulocyte Chemoattractant 5-Oxo-6,8,11,14-Eicosatetraenoic Acid (5-oxo-ETE) [J].
Chourey, Shishir ;
Ye, Quji ;
Reddy, Chintam Nagendra ;
Wang, Rui ;
Cossette, Chantal ;
Gravel, Sylvie ;
Slobodchikova, Irina ;
Vuckovic, Dajana ;
Rokach, Joshua ;
Powell, William S. .
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (14) :5934-5948
[49]   A COMPARISON OF THE PROINFLAMMATORY EFFECTS OF 12(R)- AND 12(S)-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID IN HUMAN-SKIN [J].
WOLLARD, PM ;
CUNNIGHAM, FM ;
MURPHY, GM ;
CAMP, RDR ;
DERM, FF ;
GREAVES, MW .
PROSTAGLANDINS, 1989, 38 (04) :465-471
[50]   QUANTITATION OF 20-HYDROXY-5,8,11,14-EICOSATETRAENOIC ACID (20-HETE) PRODUCED BY HUMAN POLYMORPHONUCLEAR LEUKOCYTES USING ELECTRON-CAPTURE IONIZATION GAS-CHROMATOGRAPHY MASS-SPECTROMETRY [J].
HILL, E ;
MURPHY, RC .
BIOLOGICAL MASS SPECTROMETRY, 1992, 21 (05) :249-253